Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Net Receivables
$441.80M
Quarterly · Period ending: · USD
BIO Net Receivables
Latest reported$441.80Mperiod ending
Latest reported$441.80Mperiod ending
BIO Quarterly Net Receivables ($23.10M → $441.80M)
Quarterly net receivables
High-resolution chart · PNG
BIO net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 186,708,000 | |
| 191,792,000 | |
| 182,242,000 | |
| 182,616,000 | |
| 193,662,000 | |
| 189,574,000 | |
| 193,900,000 | |
| 105,200,000 | |
| 104,900,000 | |
| 110,400,000 | |
| 106,000,000 | |
| 96,400,000 | |
| 100,100,000 | |
| 103,100,000 | |
| 97,000,000 | |
| 89,300,000 | |
| 96,800,000 | |
| 97,100,000 | |
| 97,800,000 | |
| 88,200,000 | |
| 89,100,000 | |
| 98,200,000 | |
| 92,100,000 | |
| 85,900,000 | |
| 88,300,000 | |
| 92,500,000 | |
| 81,700,000 | |
| 81,400,000 | |
| 81,500,000 | |
| 81,900,000 | |
| 75,800,000 | |
| 77,700,000 | |
| 79,600,000 | |
| 78,100,000 | |
| 76,200,000 | |
| 73,500,000 | |
| 100,200,000 | |
| 76,400,000 | |
| 76,200,000 | |
| 71,000,000 | |
| 67,000,000 | |
| 70,000,000 | |
| 70,500,000 | |
| 62,600,000 | |
| 60,500,000 | |
| 59,900,000 | |
| 59,200,000 | |
| 53,300,000 | |
| 54,400,000 | |
| 46,700,000 | |
| 39,400,000 | |
| 28,600,000 | |
| 23,100,000 |